125290-60-0 Usage
Type of Drug
Synthetic 4th generation fluoroquinolone antibiotic
Mechanism of Action
Inhibits bacterial DNA replication and protein synthesis by inhibiting bacterial topoisomerase IV and DNA gyrase
Effective Against
Wide range of gram-positive and gram-negative bacteria, including those resistant to other antibiotics
Indications
Respiratory tract infections, skin and soft tissue infections, and urinary tract infections
Forms Available
Tablet and liquid forms
Side Effects
Nausea, diarrhea, and dizziness
Drug Group
Fluoroquinolones
Usage
Treats various bacterial infections
Tolerance
Generally well-tolerated
Resistance
Effective against bacteria resistant to other antibiotics
Prescription
Typically prescribed by healthcare professionals for serious infections
Check Digit Verification of cas no
The CAS Registry Mumber 125290-60-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,5,2,9 and 0 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 125290-60:
(8*1)+(7*2)+(6*5)+(5*2)+(4*9)+(3*0)+(2*6)+(1*0)=110
110 % 10 = 0
So 125290-60-0 is a valid CAS Registry Number.
125290-60-0Relevant articles and documents
Synthesis and Biological Activity of 5-Alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic Acids
Hagen, Susan E.,Domagala, Johan M.,Heifetz, Carl L.,Johnson, Judith
, p. 1155 - 1161 (2007/10/02)
A series of 5-alkyl-1,7,8-trisubstituted-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids was prepared and evaluated for in vitro and in vivo antibacterial activity.When compared to the 5-hydrogen analogues, the presence of the 5-methyl group enhanc
Antibacterial agents
-
, (2008/06/13)
Novel naphthyridine-, and quinolinecarboxylic acids as antibacterial agents are described as well as methods for their manufacture, formulation, and use in treating bacterial infections including the description of certain novel intermediates used in the